In essence, MyoD serves as a critical switch in the differentiation and dedifferentiation of myofibroblasts, and silencing MyoD can be a therapeutic approach for treating pulmonary fibrosis. This evidence concerns the gene MYOD1 and pulmonary fibrosis.